• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌男性雄激素剥夺治疗的并发症

Complications of androgen-deprivation therapy in men with prostate cancer.

作者信息

Chen Allen C, Petrylak Daniel P

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, 177 Fort Washington Avenue, MHB 6-435, New York, NY 10032, USA.

出版信息

Curr Urol Rep. 2005 May;6(3):210-6. doi: 10.1007/s11934-005-0009-2.

DOI:10.1007/s11934-005-0009-2
PMID:15869725
Abstract

Androgen-deprivation therapy (ADT) is indicated for the treatment of metastatic prostate cancer and locally advanced disease. In addition to sexual side effects, long-term ADT results in several other changes, including hot flashes; gynecomastia; changes in body composition, metabolism, and the cardiovascular system; osteoporosis; anemia; psychiatric and cognitive problems; and fatigue and diminished quality of life. This review discusses these complications of ADT and treatments aimed at reducing them. It is important for clinicians to anticipate these effects and to initiate measures to prevent or minimize them in order to maintain quality of life in prostate cancer survivors.

摘要

雄激素剥夺疗法(ADT)适用于转移性前列腺癌和局部晚期疾病的治疗。除了性功能副作用外,长期ADT还会导致其他一些变化,包括潮热;男性乳房发育;身体成分、代谢和心血管系统的改变;骨质疏松;贫血;精神和认知问题;以及疲劳和生活质量下降。本综述讨论了ADT的这些并发症以及旨在减少这些并发症的治疗方法。临床医生必须预见到这些影响,并开始采取措施预防或尽量减少这些影响,以维持前列腺癌幸存者的生活质量。

相似文献

1
Complications of androgen-deprivation therapy in men with prostate cancer.前列腺癌男性雄激素剥夺治疗的并发症
Curr Urol Rep. 2005 May;6(3):210-6. doi: 10.1007/s11934-005-0009-2.
2
Complications of androgen deprivation therapy in men with prostate cancer.前列腺癌男性患者雄激素剥夺治疗的并发症
Curr Oncol Rep. 2004 May;6(3):209-15. doi: 10.1007/s11912-004-0051-0.
3
Preventing and treating the complications of hormone therapy.
Curr Urol Rep. 2005 May;6(3):217-23. doi: 10.1007/s11934-005-0010-9.
4
Adverse effects of androgen deprivation therapy and strategies to mitigate them.雄激素剥夺治疗的不良反应及其缓解策略。
Eur Urol. 2015 May;67(5):825-36. doi: 10.1016/j.eururo.2014.07.010. Epub 2014 Aug 2.
5
Acupuncture for hot flashes in men treated with androgen deprivation therapy.针刺疗法治疗接受雄激素剥夺治疗的男性潮热症状。
Can J Urol. 2015 Aug;22(4):7938-41.
6
Emerging cardiometabolic complications of androgen deprivation therapy.雄激素剥夺治疗的新兴心脏代谢并发症。
Aging Male. 2010 Mar;13(1):1-9. doi: 10.3109/13685530903410625.
7
Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗期间的骨质疏松及其他不良身体成分变化
Cancer Metastasis Rev. 2002;21(2):159-66. doi: 10.1023/a:1020840311573.
8
Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.雄激素剥夺治疗的副作用:监测与毒性最小化
Urology. 2003 Feb;61(2 Suppl 1):32-8. doi: 10.1016/s0090-4295(02)02397-x.
9
Androgen deprivation therapy-associated vasomotor symptoms.雄激素剥夺治疗相关的血管舒缩症状。
Asian J Androl. 2012 Mar;14(2):193-7. doi: 10.1038/aja.2011.101. Epub 2012 Jan 30.
10
Endocrine complications of androgen-deprivation therapy in men with prostate cancer.前列腺癌男性雄激素剥夺治疗的内分泌并发症
Clin Adv Hematol Oncol. 2006 Sep;4(9):687-96.

引用本文的文献

1
Effects of Baduanjin exercise on cancer-related fatigue in patients with prostate cancer treated with androgen deprivation therapy in Shanghai, China: a study protocol for a randomised controlled trial.八段锦锻炼对中国上海接受雄激素剥夺治疗的前列腺癌患者癌因性疲乏的影响:一项随机对照试验研究方案。
BMJ Open. 2024 Nov 13;14(11):e092363. doi: 10.1136/bmjopen-2024-092363.
2
Effects of surgical and chemical castration on spatial learning ability in relation to cell proliferation and apoptosis in hippocampus.手术去势和化学去势对海马体细胞增殖和凋亡相关的空间学习能力的影响。
Int Urol Nephrol. 2016 Apr;48(4):517-27. doi: 10.1007/s11255-015-1200-0. Epub 2016 Jan 18.
3

本文引用的文献

1
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.双膦酸盐的抗肿瘤作用:从基础研究到临床证据
Ann Oncol. 2003 Oct;14(10):1468-76. doi: 10.1093/annonc/mdg401.
2
Androgen deprivation and cognition in prostate cancer.前列腺癌中的雄激素剥夺与认知
Br J Cancer. 2003 Sep 15;89(6):971-6. doi: 10.1038/sj.bjc.6601235.
3
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.唑来膦酸预防非转移性前列腺癌雄激素剥夺治疗男性骨质流失的随机对照试验。
Do hormone treatments for prostate cancer cause anxiety and depression?
前列腺癌的激素治疗会导致焦虑和抑郁吗?
Int J Clin Oncol. 2014;19(3):523-30. doi: 10.1007/s10147-013-0569-y. Epub 2013 Jun 1.
4
A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.雄激素剥夺治疗的前列腺癌男性患者运动的初步研究。
BMC Cancer. 2012 Mar 21;12:103. doi: 10.1186/1471-2407-12-103.
5
Quality of life issues in men undergoing androgen deprivation therapy: a review.男性接受雄激素剥夺治疗的生活质量问题:综述。
Asian J Androl. 2012 Mar;14(2):226-31. doi: 10.1038/aja.2011.108. Epub 2012 Jan 9.
6
Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.靶向 MMP-9、uPAR 和组织蛋白酶 B 抑制前列腺癌细胞的侵袭、迁移并激活细胞凋亡。
Cancer Gene Ther. 2010 Sep;17(9):599-613. doi: 10.1038/cgt.2010.16. Epub 2010 May 7.
7
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.环杷明前药对晚期前列腺癌的刺猬信号通路靶向抑制作用
Bioorg Med Chem. 2008 Mar 15;16(6):2764-8. doi: 10.1016/j.bmc.2008.01.012. Epub 2008 Jan 11.
8
Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy.对接受激素治疗的晚期前列腺癌男性患者抑郁和疲劳情况的前瞻性研究。
Psychooncology. 2008 Feb;17(2):148-53. doi: 10.1002/pon.1206.
J Urol. 2003 Jun;169(6):2008-12. doi: 10.1097/01.ju.0000063820.94994.95.
4
The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.与去势相比,非甾体类抗雄激素药物比卡鲁胺(“康士得”)可能会维持骨密度:一项初步研究的结果。
World J Urol. 2003 May;21(1):37-42. doi: 10.1007/s00345-003-0322-7. Epub 2003 Mar 22.
5
Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.接受雄激素剥夺治疗的前列腺癌男性患者的抗阻运动。
J Clin Oncol. 2003 May 1;21(9):1653-9. doi: 10.1200/JCO.2003.09.534.
6
Fracture risk following bilateral orchiectomy.双侧睾丸切除术后的骨折风险。
J Urol. 2003 May;169(5):1747-50. doi: 10.1097/01.ju.0000059281.67667.97.
7
Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.前列腺癌男性患者治疗相关骨质疏松症的诊断与管理
Cancer. 2003 Feb 1;97(3 Suppl):789-95. doi: 10.1002/cncr.11149.
8
Intermittent androgen suppression for prostate cancer: rationale and clinical experience.前列腺癌的间歇性雄激素抑制:理论依据与临床经验。
Prostate Cancer Prostatic Dis. 1998 Dec;1(6):289-296. doi: 10.1038/sj.pcan.4500260.
9
Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study.接受雄激素剥夺治疗的前列腺癌男性患者的抑郁情况:一项试点研究。
Psychooncology. 2002 Nov-Dec;11(6):518-23. doi: 10.1002/pon.592.
10
Effects of exercise on physiological and psychological variables in cancer survivors.运动对癌症幸存者生理和心理变量的影响。
Med Sci Sports Exerc. 2002 Dec;34(12):1863-7. doi: 10.1097/00005768-200212000-00001.